Suppr超能文献

口服尼古丁袋对公众健康的潜在影响:一项范围综述

The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.

作者信息

Travis Nargiz, Warner Kenneth E, Goniewicz Maciej L, Oh Hayoung, Ranganathan Radhika, Meza Rafael, Hartmann-Boyce Jamie, Levy David T

机构信息

Lombardi Comprehensive Cancer Center, Georgetown Medical University, Washington, DC, USA.

Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

出版信息

Nicotine Tob Res. 2025 Mar 24;27(4):598-610. doi: 10.1093/ntr/ntae131.

Abstract

INTRODUCTION

Oral nicotine pouches (ONPs) are a new class of nicotine products. This scoping review summarizes evidence on ONPs and explores their potential public health impact.

AIMS AND METHODS

We conducted a structured literature search for empirical studies across three electronic databases through January 10, 2024. Outcomes included ONP product characteristics, use patterns, beliefs and perceptions, toxicity, and marketing and sales.

RESULTS

Sixty-two studies were included, 17 were industry-funded. Most studies were from the United States. While large variations across studies were observed in ONP youth prevalence estimates, nationally representative U.S. studies find current use at 1.5% and lifetime use below 2.5% through 2023. Between 35% and 42% of U.S. adolescents and young adults have heard of ONPs, and 9-21% of tobacco-naïve youth were susceptible to trying them. U.S. adult-use estimates varied widely (0.8%-3% current; 3%-16% lifetime use) and were limited to populations with a history of tobacco use. The chemical composition of ONPs suggests fewer harmful/potentially harmful compounds at lower levels than cigarettes and smokeless tobacco (SLT), except formaldehyde. Industry-funded studies find substantially less cytotoxicity compared to cigarettes and suggest that higher nicotine-strength ONPs can deliver nicotine at levels comparable to or higher than SLT or cigarettes, although with slower nicotine release than cigarettes. Evidence on the cytotoxicity of ONPs relative to SLT is mixed.

CONCLUSIONS

ONPs appear to be less toxic than cigarettes and deliver comparable nicotine, presenting an alternative for combustible product users, although key data are mainly available from industry-funded studies. Data from independent research is critically needed. Industry marketing of ONPs may encourage initiation in youth and situational and dual use in adults.

IMPLICATIONS

The review provides an initial assessment of the potential role of ONPs in harm reduction and aims to determine unintended consequences of their use (youth uptake and dual-use) and identify populations that disproportionately use the product. This information is essential for tobacco regulatory bodies in determining the net public health impact of nicotine pouches.

摘要

引言

口服尼古丁袋是一类新型尼古丁产品。本综述总结了关于口服尼古丁袋的证据,并探讨了它们对公众健康的潜在影响。

目的和方法

我们在三个电子数据库中进行了结构化文献检索,以查找截至2024年1月10日的实证研究。结果包括口服尼古丁袋产品特征、使用模式、信念和认知、毒性以及营销和销售情况。

结果

纳入了62项研究,其中17项由行业资助。大多数研究来自美国。虽然不同研究中口服尼古丁袋在青少年中的流行率估计差异很大,但美国具有全国代表性的研究发现,截至2023年,当前使用率为1.5%,终生使用率低于2.5%。在美国,35%至42%的青少年和年轻人听说过口服尼古丁袋,9%至21%从未使用过烟草的年轻人容易尝试使用。美国成年人的使用估计差异很大(当前使用率为0.8%至3%;终生使用率为3%至16%),且仅限于有吸烟史的人群。口服尼古丁袋的化学成分表明,除甲醛外,其有害/潜在有害化合物的含量低于香烟和无烟烟草,且含量较低。行业资助的研究发现,与香烟相比,口服尼古丁袋的细胞毒性要小得多,并表明尼古丁强度较高的口服尼古丁袋可以提供与无烟烟草或香烟相当或更高水平的尼古丁,尽管尼古丁释放速度比香烟慢。关于口服尼古丁袋相对于无烟烟草的细胞毒性的证据不一。

结论

口服尼古丁袋似乎比香烟毒性小,且能提供相当的尼古丁量,这为可燃产品使用者提供了一种替代选择,不过关键数据主要来自行业资助的研究。迫切需要独立研究的数据。口服尼古丁袋的行业营销可能会鼓励年轻人开始使用,并导致成年人出现情境性使用和双重使用的情况。

启示

本综述对口服尼古丁袋在减少危害方面的潜在作用进行了初步评估,旨在确定其使用的意外后果(年轻人使用和双重使用),并确定使用该产品比例过高的人群。这些信息对于烟草监管机构确定尼古丁袋对公众健康的净影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e80/11931220/5ecb52d9a718/ntae131_fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验